This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Baystate Health, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Sabyasachi Sen: Innovator in Diabetes Treatment
Introduction
Sabyasachi Sen is a notable inventor based in Longmeadow, MA (US). He has made significant contributions to the field of medical science, particularly in the treatment of diabetes. His innovative approach focuses on utilizing endothelial progenitor cells to address vascular deficiencies in diabetic patients.
Latest Patents
Sabyasachi Sen holds a patent for "p53 silenced endothelial progenitor cells for diabetes." This invention provides methods for treating vascular deficiencies, including those in diabetic subjects, by transplanting endothelial progenitor cells with transiently reduced p53 expression. This groundbreaking work has the potential to improve the quality of life for many individuals suffering from diabetes.
Career Highlights
Sen is affiliated with Baystate Health, Inc., where he continues to advance his research and innovations. His work is characterized by a commitment to finding effective solutions for complex medical challenges.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Sabyasachi Sen's contributions to diabetes treatment through his innovative patent demonstrate his dedication to improving healthcare outcomes. His work exemplifies the impact of scientific research on real-world medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile